Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases
Westberg, M., Su, Y., Zou, X., Rustagi, A., Beck, A., Ning, L., Fernandez, D., Blish, C., Lin, M.Z.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
3C-like proteinase | 306 | Severe acute respiratory syndrome coronavirus 2 | Mutation(s): 0 Gene Names: rep, 1a-1b EC: 3.4.22.69 | ![]() | |
UniProt | |||||
Find proteins for P0DTD1 (Severe acute respiratory syndrome coronavirus 2) Explore P0DTD1 Go to UniProtKB: P0DTD1 | |||||
Entity Groups | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P0DTD1 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
99W (Subject of Investigation/LOI) Query on 99W | E [auth A], F [auth B], G [auth C], H [auth D] | (S)-N-((S)-1-imino-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-4-methyl-2-(2-((2,4,6-trifluorophenyl)amino)acetamido)pentanamide C21 H28 F3 N5 O3 ZQILDLPZFYNMME-OGBZPUTOSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 67.538 | α = 90 |
b = 102.523 | β = 91.59 |
c = 102.487 | γ = 90 |
Software Name | Purpose |
---|---|
REFMAC | refinement |
SCALA | data scaling |
PHASER | phasing |
PDB_EXTRACT | data extraction |
DIALS | data reduction |
Funding Organization | Location | Grant Number |
---|---|---|
Novo Nordisk Foundation | NNF18OC0031816 | |
Other private | -- |